查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942992

酚红市场按形态、通路、应用和最终用途产业划分，全球预测（2026-2032年）

Phenol Red Market by Form, Distribution Channel, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，酚红市场价值将达到 5,572 万美元，到 2026 年将成长到 5,965 万美元，到 2032 年将达到 8,621 万美元，复合年增长率为 6.43%。

关键市场统计数据
基准年 2025 5572万美元
预计年份：2026年 5965万美元
预测年份 2032 8621万美元
复合年增长率 (%) 6.43%

酚红的全面介绍：其生化作用、实验室实际应用、供应链背景及其日益增长的重要性

酚红作为一种可靠的pH指示剂和细胞培养基的标准添加剂，在生命科学实验室和工业应用中占据着重要的战略地位。它在细胞培养基、诊断剂和工业试剂池中的广泛应用，既体现了其化学稳定性，也反映了其在实验室操作流程中的根深蒂固。过去十年间，酚红的作用已不再局限于简单的pH指示，其配方、来源和监管状态都会影响实验的可重复性、品管以及下游产品开发週期。

分析重塑酚红需求的变革性变化，包括科学创新、永续性预期和监管压力

多种颠覆性因素正在重塑酚红产业格局，改变生产、配方和终端应用领域的重点。细胞和基因疗法的进步、更复杂的生物製药以及高通量筛检方法的普及，推动了对具有明确杂质谱、严格公差和详细可追溯性的试剂的需求。这项科学进步迫使供应商投资改善分析控制，并提供满足治疗研发和法规环境严苛要求的等级产品。

评估美国关税在2025年对酚红供应链、筹资策略和商业营运的累积影响

美国2025年生效的关税政策带来了一系列营运和商业上的复杂性，波及整个酚红供应链，影响了原料成本、筹资策略和下游采购行为。关税提高了进口原材料和成品的成本，迫使买家重新评估其供应商组合，并寻求替代方案以在不影响品质的前提下降低额外成本。这种动态促使采购团队立即考虑与国内或区域供应商签订短期合同，并评估持有奖励和频繁补货的经济效益。

针对酚红相关人员的关键细分洞察，重点在于产品形态偏好、应用领域、终端用户行为以及对分销管道的影响

分段观点有助于釐清酚红生态系的需求模式，并突显机会与风险领域。依应用领域划分，酚红用户涵盖细胞培养基、pH指示剂溶液以及泳池和水疗化学品，其中细胞培养基类别可细分为昆虫细胞培养、哺乳动物细胞培养和微生物细胞培养。每种应用途径都对品质和文件有独特的要求。细胞培养应用通常需要更高的纯度、检验的生产批次以及符合监管要求的分析证书。同时，pH指示剂溶液强调在各种化学条件下保持一致的颜色响应和稳定性，而泳池和水疗组合药物优先考虑成本效益和符合消费品法规的要求。

对美洲、欧洲、中东和非洲以及亚太地区的需求驱动因素、生产地点、法规环境和贸易趋势进行区域分析

区域趋势对酚红的供应、监管应对和商业策略有显着影响。在美洲，生产能力集中在成熟的化学和生命科学製造群中，这些集群利用了其接近性主要生物技术中心和大规模机构买家的优势。这种集中化有利于快速週转和提供先进的技术服务，但也使得区域政策变化和当地原材料供应的影响更加集中。美洲的需求受到活跃的学术活动、不断扩展的生物製药研发管线以及日益重视供应链透明度的采购环境的影响。

战略情报揭示酚红生产商的生产投资、合作模式、创新重点和竞争地位

供应商和生产商的企业策略表明，他们采取了防御性和成长性相结合的策略，旨在抢占高价值细分市场并管控风险。对生产设施升级和分析能力的投资是反覆出现的主题，这使得企业能够提供差异化等级的产品，提高纯度指标，并完善符合监管和GMP要求的文件资料。随着越来越多的企业寻求整合自身能力以加速客户采纳并缩短关键应用领域的应用时间，合作模式（包括与试剂配方商的共同开发契约以及与物流供应商的策略联盟）正变得越来越普遍。

为产业领导者提供优先考虑且切实可行的建议，以降低供应风险、加速产品创新并加强分销能力

产业领导者应采取一系列切实可行的措施，以增强韧性、维护科学诚信并实现商业性差异化。首先，采购团队应实施供应商多元化策略，包括对二级生产商进行资格认证、建立区域缓衝库存以及协商灵活的合约条款以适应监管检验的时间要求。将品质保证负责人纳入供应商选择和存取流程，可降低供应中断的风险并保障实验的可重复性。

透明的调查方法，清楚概述了资料来源、与关键专家的合作、抽样方法、检验通讯协定和分析技术。

本分析所依据的研究结合了定性和定量方法，以确保对研究结果进行可靠的三角验证。主要利害关係人包括来自学术界、製药公司和生物技术公司的采购主管、品质保证专业人员和研发科学家，他们接受了结构化访谈。这些访谈揭示了营运重点、采购限制和产品性能预期。同时，对供应商的访谈和实地调查则提供了有关生产实践、产能限制和品管系统的详细情况。

一份权威、全面的分析报告，重点阐述了酚红价值链中采购、研发优先级、法规遵从性和业务永续营运方面受到的影响。

从应用领域、产品形式、终端用户产业和分销管道收集的证据描绘出一幅产业图景：技术要求与供应链考量紧密相连。治疗药物研发和受监管生产对高纯度产品的需求，与学术机构和工业用户对成本的合理要求并存，这为能够以具有竞争力的价格提供有据可查的品质保证的供应商创造了市场细分机会。同时，政策措施和贸易趋势也日益凸显了供应链多元化和区域能力的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依形式分類的酚红市场

  • 液体
  • 粉末

9. 按分销管道分類的酚红市场

  • 直销
  • 分销商/批发商
  • 电子商务

第十章 依应用分類的酚红市场

  • 细胞培养基
    • 昆虫细胞培养
    • 哺乳动物细胞培养
    • 微生物细胞培养
  • pH指示剂溶液
  • 泳池和水疗中心化学品

第十一章 以最终用途产业分類的酚红市场

  • 学术研究
  • 生物技术
  • 化学製造
  • 製药

第十二章 酚红市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 酚红市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国酚红市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国酚红市场

第十六章 中国酚红市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • American Type Culture Collection
  • Amresco, LLC
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cayman Chemical Company
  • Hach Company
  • HiMedia Laboratories Limited
  • Merck KGaA
  • MilliporeSigma, LLC
  • Nacalai Tesque, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
Product Code: MRR-F847BD9C7177

The Phenol Red Market was valued at USD 55.72 million in 2025 and is projected to grow to USD 59.65 million in 2026, with a CAGR of 6.43%, reaching USD 86.21 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 55.72 million
Estimated Year [2026] USD 59.65 million
Forecast Year [2032] USD 86.21 million
CAGR (%) 6.43%

Comprehensive introduction to phenol red covering its biochemical role, practical laboratory applications, supply chain context and emerging relevance

Phenol red occupies a strategic position in life-science laboratories and industrial applications as a robust pH indicator and a routine additive in cell culture formulations. Its ubiquity in cell culture media, diagnostic reagents and industrial pools reflects both its chemical stability and the entrenched workflows of laboratory practice. Over the past decade, the compound's role has evolved beyond mere pH indication to become a material whose formulation, provenance and regulatory status affect experimental reproducibility, quality control and downstream product development timelines.

Scientific trends such as the rise of biologics, intensified academic research into cellular models, and expanding biotechnology pipelines have reinforced demand for high-purity reagents and greater assurance of lot-to-lot consistency. Concurrently, manufacturers and users face heightened scrutiny around supply chain transparency, raw material sourcing and environmental compliance. These pressures intersect with operational realities: lead times, production capacity, packaging formats and distribution routes all influence the availability of phenol red for critical applications.

Taken together, the landscape requires stakeholders to balance technical specifications with procurement discipline. Laboratories prioritize validated grades and certificates of analysis, while producers must manage scale, quality control and regulatory documentation. As such, a comprehensive understanding of phenol red's functional role, supply dynamics and quality expectations is essential for leaders who must align scientific needs with operational and commercial strategies.

Analysis of transformative shifts reshaping phenol red demand including scientific innovation, sustainability expectations and regulatory pressure

Several transformative forces are reshaping the phenol red landscape, altering emphases across production, formulation and end-use behavior. Advances in cell and gene therapies, more complex biologics and high-throughput screening approaches are increasing demand for reagents with defined impurity profiles, tighter tolerances and detailed traceability. This scientific progression pressures suppliers to invest in improved analytical controls and to offer grades that meet the stringent needs of therapeutic development and regulated environments.

Sustainability expectations and regulatory tightening are compelling manufacturers to re-evaluate raw material sourcing and manufacturing footprints. Buyers increasingly prioritize suppliers that can demonstrate lower environmental impact, responsible chemical management and compliance with evolving chemical regulations. As a result, producers are adapting by optimizing processes to reduce waste, improve solvent recovery and adopt greener chemistries where feasible, which in turn affects cost structures and capital allocation.

Digital transformation is another pivotal shift. Laboratory automation, e-commerce procurement channels and enhanced traceability systems are changing how buyers discover, qualify and transact for phenol red. Real-time inventory visibility and digital quality documentation shorten procurement cycles and enable closer alignment between demand forecasts and production planning. Finally, market fragmentation through product differentiation-such as specialized formulations and pre-qualified lots for critical applications-has created new commercial dynamics that prioritize flexibility, responsiveness and value-added services alongside traditional product metrics.

Evaluation of the cumulative effects of United States tariff actions in 2025 on phenol red supply chains, procurement strategies and commercial operations

The tariff measures implemented by the United States in 2025 introduced a set of operational and commercial complications that ripple through the phenol red supply chain, affecting raw material costs, sourcing strategies and downstream procurement behavior. Tariffs elevated the cost basis for imported inputs and imported finished goods, prompting buyers to reassess supplier portfolios and to explore alternatives that mitigate incremental expense without compromising quality. This dynamic has created immediate incentives for procurement teams to seek nearer-term contracts with domestic or regional suppliers and to evaluate the economics of stockholding versus frequent replenishment.

In practical terms, the tariffs intensified scrutiny of total landed cost and of non-tariff barriers such as customs clearance times and additional documentation. The result was an increase in preference for suppliers with established logistical capabilities and localized warehousing that could absorb customs friction. For manufacturers, the policy environment accelerated conversations around regional capacity expansion and dual-sourcing, as firms sought to reduce vulnerability to trade policy shifts and to maintain continuity for critical customers in regulated sectors.

Operationally, the tariffs also influenced product pricing strategies and contract negotiations. Companies with forward-looking procurement functions used hedging mechanisms, indexed contract clauses and renegotiated terms to preserve margins and maintain supply continuity. Meanwhile, quality assurance and regulatory teams needed to validate substitutions where suppliers changed sourcing in response to cost pressure. Taken together, the tariffs in 2025 catalyzed a reorientation toward supply chain resilience, intensified margin management and a renewed emphasis on the strategic alignment of procurement, production and regulatory functions.

Key segmentation-driven insights revealing product form preferences, application niches, end user behavior and distribution channel implications for phenol red stakeholders

A segmentation-led view clarifies demand patterns and illuminates where opportunities and risks concentrate across the phenol red ecosystem. Based on Application, users span Cell Culture Media, pH Indicator Solutions and Pool and Spa Chemicals, with the Cell Culture Media category further divided into Insect Cell Culture, Mammalian Cell Culture and Microbial Cell Culture. Each application pathway imposes distinct quality and documentation requirements: cell culture applications typically demand higher purity, validated production lots and certificates of analysis that align with regulatory submissions, whereas pH indicator solutions emphasize consistent color response and stability under diverse chemical conditions, and pool and spa formulations prioritize cost efficiency and regulatory compliance for consumer-facing products.

Based on Form, offerings exist as Liquid and Powder, and this distinction influences logistics, shelf life and unit economics. Liquid formulations offer convenience and reduced preparation time for end users but incur higher shipping weight and specialized packaging, while powder formats provide advantages in transport efficiency, storage longevity and flexible reconstitution for diverse lab protocols. Storage and handling considerations therefore drive buyer preference in tandem with institutional procurement policies.

Based on End Use Industry, phenol red serves Academic Research, Biotechnology, Chemical Manufacturing and Pharmaceutical sectors, each with unique procurement cycles, quality expectations and compliance obligations. Academic laboratories may prioritize cost-effectiveness and rapid availability, whereas pharmaceutical and biotechnology customers require rigorous supply chain traceability and quality systems for regulatory submissions. Based on Distribution Channel, access to product is facilitated through Direct Sales, Distributors/Wholesalers and E-Commerce, with each route affecting lead times, technical support and purchasing behaviors. Direct sales relationships enable customized service and contract terms for large users, distributors provide breadth and regional reach for mid-market buyers, and e-commerce platforms deliver convenience and rapid fulfillment for smaller laboratories.

Regionally focused intelligence on demand drivers, production hubs, regulatory environments and trade dynamics across Americas, EMEA and Asia-Pacific territories

Regional dynamics materially influence supply availability, regulatory engagement and commercial strategies for phenol red. In the Americas, production capabilities are concentrated around established chemical and life-science manufacturing clusters that benefit from proximity to major biotech hubs and large institutional buyers. This concentration supports short lead times and high levels of technical service, but it also concentrates exposure to regional policy changes and local feedstock availability. Demand in the Americas is shaped by robust academic activity, expanding biopharma pipelines and a procurement environment that increasingly values supply chain transparency.

Europe, Middle East & Africa presents a heterogeneous landscape where stringent chemical regulations and a strong emphasis on sustainability drive supplier credentialing and documentation. Buyers in these jurisdictions place premium value on environmental compliance, certification and reliable quality systems. Market participants operating here must navigate diverse regulatory frameworks and a complex trade environment that rewards local compliance expertise and adaptive logistics. Cross-border trade within the region often requires meticulous attention to labeling, transport standards and chemical safety dossiers.

Asia-Pacific is characterized by both large manufacturing capacity and rapidly growing end-use demand, particularly in biotechnology research and industrial chemical applications. Production hubs across the region offer cost advantages and scale, while strong domestic innovation ecosystems are fueling demand for higher-grade reagents. However, the region's trade flows and logistics networks can be sensitive to policy shifts and raw material sourcing constraints, prompting international buyers to weigh lead time, quality certification and supplier reliability when selecting partners. Across all regions, strategic inventory placement and diversified sourcing remain critical levers for resilience.

Strategic intelligence revealing manufacturing investments, collaboration models, innovation priorities and competitive positioning of phenol red producers

Corporate strategies among suppliers and producers reveal a blend of defensive and growth-oriented actions designed to manage risk while capturing higher-value segments. Investment in manufacturing upgrades and analytical capabilities has been a recurring theme, enabling firms to offer differentiated grades with enhanced purity metrics and expanded documentation packages that meet regulatory and GMP-adjacent expectations. Collaboration models, including co-development agreements with reagent formulators and strategic partnerships with logistics providers, have become more commonplace as companies seek to integrate capabilities that accelerate customer onboarding and reduce time-to-use for critical applications.

Competition is further defined by the degree of vertical integration and geographic footprint. Manufacturers that vertically integrate raw material processing through finished product packaging enjoy tighter control of quality and supply continuity, which can be a decisive advantage for customers in regulated industries. Conversely, specialized producers that focus on high-purity grades leverage technical expertise, niche certifications and responsive customer support to differentiate from commodity suppliers.

Innovation priorities center on product customization, faster lead times and digital services such as lot-level traceability portals and online technical documentation. Firms that couple technical competence with flexible commercial models-such as tailored supply agreements, managed inventory and technical training-tend to secure longer-term engagements. Mergers and acquisitions, selective capacity expansion and targeted investments in sustainability and compliance capabilities are among the primary mechanisms companies use to sustain competitive positioning and to respond to evolving customer expectations.

Prioritized and actionable recommendations for industry leaders to mitigate supply risk, accelerate product innovation and strengthen distribution capabilities

Industry leaders must adopt a pragmatic set of actions that enhance resilience, preserve scientific integrity and create commercial differentiation. First, procurement teams should implement supplier diversification strategies that include qualifying secondary producers, establishing regional buffer inventories and negotiating flexible contract terms that accommodate regulatory validation timelines. Embedding quality assurance representatives in supplier selection and onboarding processes will reduce the risk of disruptive substitutions and protect experimental reproducibility.

Second, companies should invest in product and process innovation that aligns with customer needs. This means developing documented, traceable grades for therapeutic development, offering both liquid and powder formats optimized for end-use scenarios, and delivering value-added services such as lot-specific analytical dossiers and stability data. R&D investments that reduce impurities and enhance shelf stability translate directly into reduced downstream risk for customers and competitive premium for suppliers.

Third, strengthen distribution and commercial channels by leveraging direct sales for large institutional customers, partnerships with distributors for regional reach, and optimized e-commerce experiences for smaller buyers. Digital tools that provide real-time inventory visibility, certificate access and ordering automation improve customer satisfaction and reduce procurement friction. Finally, engage proactively with regulators and industry consortia to anticipate compliance shifts, and implement environmental and chemical stewardship programs that respond to buyer expectations and reduce long-term operational risk.

Transparent research methodology describing data sources, primary expert engagement, sampling approaches, validation protocols and analytical techniques

The research underpinning this analysis combined qualitative and quantitative approaches to ensure robust, triangulated findings. Primary engagement included structured interviews with procurement leads, quality assurance professionals and R&D scientists across academic, pharmaceutical and biotechnology organizations. These conversations illuminated practical priorities, procurement constraints and product performance expectations. In parallel, supplier interviews and site-level inquiries provided visibility into manufacturing practices, capacity constraints and quality control regimes.

Secondary research relied on technical literature, regulatory guidance documents and publicly available company disclosures to contextualize primary insights and to map relevant policy drivers. Data triangulation was achieved by cross-referencing interview evidence with operational indicators such as production announcements, import/export trends and industry commentary. Analytical techniques included comparative supplier profiling, scenario analysis for supply chain disruption, and qualitative synthesis to translate technical nuances into operational implications.

Validation protocols involved follow-up consultations with subject-matter experts to vet key assumptions and to refine recommendations. Limitations of the study are acknowledged, including potential variability in supplier disclosures and evolving policy environments that require periodic reassessment. Where applicable, sensitivity checks were applied to non-sensitive operational scenarios to confirm the robustness of conclusions and to inform prioritized action items.

Conclusive synthesis highlighting procurement, R&D prioritization, regulatory engagement and operational resilience implications across the phenol red value chain

The evidence gathered across applications, forms, end-use industries and distribution channels points to a sector in which technical requirements and supply chain considerations are tightly coupled. High-purity demands from therapeutic development and regulated manufacturing coexist with pragmatic cost sensitivity in academic and industrial users, creating segmentation opportunities for suppliers that can deliver documented quality at competitive price points. At the same time, policy measures and trade dynamics have heightened the premium on supply chain diversification and regional capability.

For stakeholders, the strategic implications are clear: align procurement processes with technical teams to ensure specification fidelity; invest in supplier qualification and traceability to mitigate substitution risk; and adopt flexible distribution strategies that combine direct, distributor and digital channels. R&D prioritization should emphasize impurity reduction, formulation flexibility and stability gains that directly address user pain points. Regulatory engagement and sustainability commitments will continue to be differentiators that affect buyer selection and long-term partnerships.

Overall, a combination of operational rigor, technical differentiation and proactive policy engagement will enable organizations to navigate current complexities and to position themselves advantageously as scientific advancements and commercial demands evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Phenol Red Market, by Form

  • 8.1. Liquid
  • 8.2. Powder

9. Phenol Red Market, by Distribution Channel

  • 9.1. Direct Sales
  • 9.2. Distributors/Wholesalers
  • 9.3. E-Commerce

10. Phenol Red Market, by Application

  • 10.1. Cell Culture Media
    • 10.1.1. Insect Cell Culture
    • 10.1.2. Mammalian Cell Culture
    • 10.1.3. Microbial Cell Culture
  • 10.2. pH Indicator Solutions
  • 10.3. Pool And Spa Chemicals

11. Phenol Red Market, by End Use Industry

  • 11.1. Academic Research
  • 11.2. Biotechnology
  • 11.3. Chemical Manufacturing
  • 11.4. Pharmaceutical

12. Phenol Red Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Phenol Red Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Phenol Red Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Phenol Red Market

16. China Phenol Red Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. American Type Culture Collection
  • 17.6. Amresco, LLC
  • 17.7. Avantor, Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. Cayman Chemical Company
  • 17.11. Hach Company
  • 17.12. HiMedia Laboratories Limited
  • 17.13. Merck KGaA
  • 17.14. MilliporeSigma, LLC
  • 17.15. Nacalai Tesque, Inc.
  • 17.16. Santa Cruz Biotechnology, Inc.
  • 17.17. Thermo Fisher Scientific Inc.
  • 17.18. Tokyo Chemical Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHENOL RED MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHENOL RED MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHENOL RED MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHENOL RED MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHENOL RED MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHENOL RED MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHENOL RED MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHENOL RED MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHENOL RED MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHENOL RED MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHENOL RED MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHENOL RED MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHENOL RED MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHENOL RED MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHENOL RED MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHENOL RED MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTORS/WHOLESALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTORS/WHOLESALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTORS/WHOLESALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHENOL RED MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHENOL RED MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHENOL RED MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHENOL RED MARKET SIZE, BY INSECT CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHENOL RED MARKET SIZE, BY INSECT CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHENOL RED MARKET SIZE, BY INSECT CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHENOL RED MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHENOL RED MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHENOL RED MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHENOL RED MARKET SIZE, BY MICROBIAL CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHENOL RED MARKET SIZE, BY MICROBIAL CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHENOL RED MARKET SIZE, BY MICROBIAL CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHENOL RED MARKET SIZE, BY PH INDICATOR SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHENOL RED MARKET SIZE, BY PH INDICATOR SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHENOL RED MARKET SIZE, BY PH INDICATOR SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHENOL RED MARKET SIZE, BY POOL AND SPA CHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHENOL RED MARKET SIZE, BY POOL AND SPA CHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHENOL RED MARKET SIZE, BY POOL AND SPA CHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHENOL RED MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHENOL RED MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHENOL RED MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHENOL RED MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHENOL RED MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHENOL RED MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHENOL RED MARKET SIZE, BY CHEMICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHENOL RED MARKET SIZE, BY CHEMICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHENOL RED MARKET SIZE, BY CHEMICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHENOL RED MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHENOL RED MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHENOL RED MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHENOL RED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS PHENOL RED MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHENOL RED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GCC PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. GCC PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GCC PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 113. GCC PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 126. G7 PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. G7 PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. G7 PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. G7 PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 131. G7 PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NATO PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 134. NATO PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NATO PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. NATO PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 137. NATO PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)